22821-73-4 Usage
Medical Use
Treats inflammatory bowel diseases like ulcerative colitis and Crohn's disease
Mechanism of Action
Reduces inflammation in the colon and intestines
Drug Class
Aminosalicylates
Chemical Structure
Contains a sulfonamide group
Forms Available
Oral tablets, capsules, rectal suspensions
Safety and Efficacy
Generally safe and effective under healthcare professional guidance
Common Side Effects
Headache, nausea, diarrhea, abdominal pain
Check Digit Verification of cas no
The CAS Registry Mumber 22821-73-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,8,2 and 1 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 22821-73:
(7*2)+(6*2)+(5*8)+(4*2)+(3*1)+(2*7)+(1*3)=94
94 % 10 = 4
So 22821-73-4 is a valid CAS Registry Number.
22821-73-4Relevant articles and documents
NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS
-
Page/Page column 74, (2015/12/08)
A compound of formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
